Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

BACKGROUND: Colorectal cancer (CRC) remains one of the major cancer types and cancer related death worldwide. Sensitive, non-invasive biomarkers that can facilitate disease detection, staging and prediction of therapeutic outcome are highly desirable to improve survival rate and help to determine op...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hanyin, Zhang, Lina, Cogdell, David E., Zheng, Hong, Schetter, Aaron J., Nykter, Matti, Harris, Curtis C., Chen, Kexin, Hamilton, Stanley R., Zhang, Wei
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060165/
https://www.ncbi.nlm.nih.gov/pubmed/21445232
http://dx.doi.org/10.1371/journal.pone.0017745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060165/
https://www.ncbi.nlm.nih.gov/pubmed/21445232
http://dx.doi.org/10.1371/journal.pone.0017745

Ejemplares similares